Contents

Current Pharmaceutical Design, Volume 8 - Number 15

Preface

, 8(15): i

Laurence H. Patterson


DOI: 10.2174/1381612023394638




Antiangiogenic, Bioreductive and Gene Therapy Approaches to the Treatment of Hypoxic Tumours

, 8(15): 1319 - 1333

Virginia A. Mc Nally, Adam V. Patterson, Kaye J. Williams, Rachel L. Cowen, Ian J. Stratford and Mohammed Jaffar


DOI: 10.2174/1381612023394548




Tumour Cytochrome P450 and Drug Activation

, 8(15): 1335 - 1347

Laurence H. Patterson and Graeme I. Murray


DOI: 10.2174/1381612023394502




Nitroreductase-based GDEPT

, 8(15): 1349 - 1361

William A. Denny


DOI: 10.2174/1381612023394584




Indole-3-Acetic Acids and Horseradish Peroxidase: A New Prodrug / Enzyme Combination for Targeted Cancer Therapy

, 8(15): 1363 - 1374

Peter Wardman


DOI: 10.2174/1381612023394610




Duocarmycins - Natures Prodrugs?

, 8(15): 1375 - 1389

Mark Searcey


DOI: 10.2174/1381612023394539




Beta-Glucuronidase-Mediated Drug Release

, 8(15): 1391 - 1403

Michelle de Graaf, Epie Boven, Hans W. Scheeren, Hidde J. Haisma and Herbert M. Pinedo


DOI: 10.2174/1381612023394485




Cytochrome P450 Gene-directed Enzyme Prodrug Therapy (GDEPT) for Cancer

, 8(15): 1405 - 1416

Ling Chen and David J. Waxman


DOI: 10.2174/1381612023394566




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science